Advanced search
Publication Cover
Expert Opinion on Pharmacotherapy Volume 20, 2019 - Issue 3
Submit an article Journal homepage
1,238
Views
0
CrossRef citations to date
0
Altmetric
Editorial

Considerations when selecting pharmacotherapy for nicotine dependence

Seetal DoddSchool of Medicine, IMPACT SRC, Deakin University, Geelong, Australia;Centre for Youth Mental Health and Orygen, The National Centre of Excellence in Youth Mental Health, University of Melbourne, Parkville, Australia;Department of Psychiatry, University of Melbourne, Parkville, Australia;Barwon Health, University Hospital Geelong, Geelong, AustraliaCorrespondence[email protected]
ORCID Iconhttp://orcid.org/0000-0002-7918-4636View further author information
ORCID Icon,
Lauren AranciniSchool of Medicine, IMPACT SRC, Deakin University, Geelong, Australia;Barwon Health, University Hospital Geelong, Geelong, AustraliaView further author information
,
Nieves Gómez-CoronadoDepartment of Psychiatry, Hospital San Agustín-ORL, Seville, SpainORCID Iconhttp://orcid.org/0000-0001-5277-9595View further author information
ORCID Icon,
Rudi GasserBarwon Health, University Hospital Geelong, Geelong, AustraliaView further author information
,
Dan I LubmanTurning Point, Eastern Health, Melbourne, Australia;Eastern Health Clinical School, Monash University, Melbourne, AustraliaORCID Iconhttp://orcid.org/0000-0002-6747-1937View further author information
ORCID Icon,
Olivia M DeanSchool of Medicine, IMPACT SRC, Deakin University, Geelong, Australia;Department of Psychiatry, University of Melbourne, Parkville, Australia;Barwon Health, University Hospital Geelong, Geelong, Australia;Florey Institute for Neuroscience and Mental Health, University of Melbourne, Parkville, AustraliaORCID Iconhttp://orcid.org/0000-0002-2776-3935View further author information
ORCID Icon &
Michael BerkSchool of Medicine, IMPACT SRC, Deakin University, Geelong, Australia;Centre for Youth Mental Health and Orygen, The National Centre of Excellence in Youth Mental Health, University of Melbourne, Parkville, Australia;Department of Psychiatry, University of Melbourne, Parkville, Australia;Barwon Health, University Hospital Geelong, Geelong, Australia;Florey Institute for Neuroscience and Mental Health, University of Melbourne, Parkville, AustraliaORCID Iconhttp://orcid.org/0000-0002-5554-6946View further author information
ORCID Icon show all
Pages 245-250 | Received 12 Jul 2018, Accepted 15 Nov 2018, Published online: 29 Nov 2018

References

  • Gomez-Coronado N, Walker AJ, Berk M, et al. Current and emerging pharmacotherapies for cessation of tobacco smoking. Pharmacotherapy. 2018 Feb;38(2):235–258.
  • Cook BL, Wayne GF, Kafali EN, et al. Trends in smoking among adults with mental illness and association between mental health treatment and smoking cessation. JAMA. 2014 Jan 8;311(2):172–182.
  • Stead LF, Buitrago D, Preciado N, et al. Physician advice for smoking cessation. Cochrane Database Syst Rev. 2013 May;31(5):CD000165.
  • Prochaska JJ, Gill P, Hall SM. Treatment of tobacco use in an inpatient psychiatric setting. Psychiatr Serv. 2004 Nov;55(11):1265–1270.
  • Rigotti NA, Regan S, Levy DE, et al. Sustained care intervention and postdischarge smoking cessation among hospitalized adults: a randomized clinical trial. JAMA. 2014 Aug 20;312(7):719–728.
  • Stead LF, Perera R, Bullen C, et al. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev. 2012 Nov 14;11:CD000146.
  • Hartmann-Boyce J, Stead LF, Cahill K, et al. Efficacy of interventions to combat tobacco addiction: cochrane update of 2013 reviews. Addiction. 2014 Sep;109(9):1414–1425.
  • Ebbert JO, Hughes JR, West RJ, et al. Effect of varenicline on smoking cessation through smoking reduction: a randomized clinical trial. JAMA. 2015 Feb 17;313(7):687–694.
  • Adkison SE, O’Connor RJ, Bansal-Travers M, et al. Electronic nicotine delivery systems: international tobacco control four-country survey. Am J Prev Med. 2013 Mar;44(3):207–215.
  • Hartmann-Boyce J, McRobbie H, Bullen C, et al. Electronic cigarettes for smoking cessation. Cochrane Database Syst Rev. 2016 Sep 14;9:CD010216.
  • Pepper JK, Brewer NT. Electronic nicotine delivery system (electronic cigarette) awareness, use, reactions and beliefs: a systematic review. Tob Control. 2014 Sep;23(5):375–384.
  • Hughes JR, Stead LF, Hartmann-Boyce J, et al. Antidepressants for smoking cessation. Cochrane Database Syst Rev. 2014 Jan;8(1):CD000031.
  • Prado E, Maes M, Piccoli LG, et al. N-acetylcysteine for therapy-resistant tobacco use disorder: a pilot study. Redox Rep. 2015 Sep;20(5):215–222.
  • Grella SL, Funk D, Coen K, et al. Role of the kappa-opioid receptor system in stress-induced reinstatement of nicotine seeking in rats. Behav Brain Res. 2014 May 15;265:188–197.
  • Halpern SD, Harhay MO, Saulsgiver K, et al. A pragmatic trial of E-cigarettes, incentives, and drugs for smoking cessation. N Engl J Med. 2018 Jun 14;378(24):2302–2310.
  • Hartmann-Boyce J, Cahill K, Hatsukami D, et al. Nicotine vaccines for smoking cessation. Cochrane Database Syst Rev. 2012 Aug;15(8):CD007072.
  • Schoberberger R, Bohm G, Schroeder Y. Heavy dependent nicotine smokers–newfound lifestyle appreciation after quitting successfully. Experiences from inpatient smoking cessation therapy. Public Health. 2015 May;129(5):539–544.
  • Benowitz NL. Clinical pharmacology of nicotine: implications for understanding, preventing, and treating tobacco addiction. Clin Pharmacol Ther. 2008 Apr;83(4):531–541.
  • Sansores RH, Ramirez-Venegas A, Arellano-Rocha R, et al. Use of varenicline for more than 12 months for smoking cessation in heavy chronic obstructive pulmonary disease smokers unmotivated to quit: a pilot study. Ther Adv Respir Dis. 2016 Oct;10(5):383–390.
  • Prochaska JJ, Das S, Young-Wolff KC. Smoking, mental illness, and public health. Annu Rev Public Health. 2017 Mar 20;38:165–185.
  • Taylor G, McNeill A, Girling A, et al. Change in mental health after smoking cessation: systematic review and meta-analysis. Bmj. 2014 Feb 13;348:g1151.
  • Thomson D, Berk M, Dodd S, et al. Tobacco use in bipolar disorder. Clin Psychopharmacol Neurosci. 2015 Apr 30;13(1):1–11.
  • Balmford J, Borland R, Hammond D, et al. Adherence to and reasons for premature discontinuation from stop-smoking medications: data from the ITC Four-Country Survey. Nicotine Tob Res. 2011 Feb;13(2):94–102.
  • Borland R, Balmford J, Swift E. Effects of timing of initiation and planning on smoking cessation outcomes: study protocol for a randomised controlled trial. BMC Public Health. 2013 Mar 18;13:235.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.